For Semaglutide injections to be most effective, avoid foods high in fat, sugar, and empty calories
[1] [2] As of 20242025, retatrutide remains under clinical investigation and has not been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom, nor by the European Medicines Agency (EMA) or the US Food and Drug Administration (FDA) for routine clinical use
It is supplied lyophilised and labelled strictly for in-vitro laboratory research use only
subcutaneous injection is a research/community practice with weak pharmacologic rationale, since the peptides plasma half-life is only minutes [4]
At 20 mg/ml, small measurement errors have bigger consequences
Having gastric surgery also increases the risk of b12 deficiency